AIN457 (secukinumab)

secukinumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AIN457 (secukinumab), covering 2016-01-14 to 2016-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis [Phase 3]